Provista Diagnostics, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Provista Diagnostics, Inc. - overview

Established

2007

Location

Alpharetta, GA, US

Primary Industry

Healthcare

About

Based in Georgia, US, and founded in 2007, Provista Diagnostics, Inc. develops and commercializes blood-based diagnostic tests. In June 2019, Ascenda BioSciences, LLC, a portfolio company of The Strategic Group, acquired Provista Diagnostics, Inc. The company's tests are used for early oncology-related disease state recognition and detection purposes.


Provista Diagnostics, Inc. also offers a biomarker panel that comes with patient data and statistical modeling to improve healthcare standard in detecting suspicious breast lesions, called Videssa Breast; a blood-based biomarker assay for early detection of ovarian cancer and recurrence monitoring, called Videssa Ovarian; and a blood-based diagnostic test for early detection and management of endometrial cancer, called Videssa Endometrial.


Current Investors

Ascenda BioSciences, LLC, Groton Partners, Louis-Dreyfus Family Office

Primary Industry

Healthcare

Sub Industries

Diagnostic, Medical & Imaging Laboratories, Oncology/Cancer Treatment

Website

www.provistadx.com

Verticals

HealthTech

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Provista Diagnostics, Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Trade SaleCompletedProvista Diagnostics, Inc.-
Trade SaleCompletedProvista Diagnostics, Inc.-
Add-onCompletedProvista Diagnostics, Inc.-

Displaying 1 - 3 of 3

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.